News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
799,424 Results
Type
Article (73199)
Company Profile (364)
Press Release (725860)
Multimedia
Podcasts (112)
Webinars (17)
Section
Business (221028)
Career Advice (2971)
Deals (37844)
Drug Delivery (123)
Drug Development (87968)
Employer Resources (187)
FDA (17534)
Job Trends (16458)
News (375898)
Policy (37055)
Tag
Academia (2986)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (108)
Alliances (54847)
ALS (122)
Alzheimer's disease (1603)
Antibody-drug conjugate (ADC) (183)
Approvals (17497)
Artificial intelligence (362)
Autoimmune disease (35)
Automation (20)
Bankruptcy (392)
Best Places to Work (12506)
BIOSECURE Act (20)
Biosimilars (138)
Biotechnology (242)
Bladder cancer (101)
Brain cancer (40)
Breast cancer (404)
Cancer (3160)
Cardiovascular disease (251)
Career advice (2505)
Career pathing (33)
CAR-T (209)
CDC (42)
Cell therapy (563)
Cervical cancer (25)
Clinical research (71943)
Collaboration (1151)
Company closure (3)
Compensation (721)
Complete response letters (36)
COVID-19 (2899)
CRISPR (69)
C-suite (388)
Cystic fibrosis (119)
Data (3241)
Decentralized trials (2)
Denatured (35)
Depression (81)
Diabetes (374)
Diagnostics (6934)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (158)
Drug pricing (154)
Drug shortages (31)
Duchenne muscular dystrophy (160)
Earnings (91232)
Editorial (50)
Employer branding (24)
Employer resources (162)
Events (126852)
Executive appointments (923)
FDA (19384)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1025)
Gene editing (151)
Generative AI (33)
Gene therapy (449)
GLP-1 (915)
Government (5236)
Grass and pollen (7)
Guidances (220)
Healthcare (20718)
HIV (45)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (188)
Immuno-oncology (13)
Indications (42)
Infectious disease (3101)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (77)
Intellectual property (128)
Interviews (570)
IPO (17288)
IRA (56)
Job creations (4378)
Job search strategy (2070)
Kidney cancer (15)
Labor market (55)
Layoffs (573)
Leadership (26)
Legal (9104)
Liver cancer (85)
Longevity (12)
Lung cancer (445)
Lymphoma (221)
Machine learning (12)
Management (64)
Manufacturing (449)
MASH (104)
Medical device (14454)
Medtech (14460)
Mergers & acquisitions (21304)
Metabolic disorders (945)
Multiple sclerosis (106)
NASH (23)
Neurodegenerative disease (158)
Neuropsychiatric disorders (44)
Neuroscience (2381)
NextGen: Class of 2025 (7388)
Non-profit (5055)
Now hiring (50)
Obesity (477)
Opinion (278)
Ovarian cancer (107)
Pain (125)
Pancreatic cancer (132)
Parkinson's disease (201)
Partnered (23)
Patents (336)
Patient recruitment (186)
Peanut (55)
People (63697)
Pharmaceutical (82)
Pharmacy benefit managers (24)
Phase I (22305)
Phase II (31391)
Phase III (23492)
Pipeline (1776)
Policy (242)
Postmarket research (3263)
Preclinical (9973)
Press Release (72)
Prostate cancer (154)
Psychedelics (46)
Radiopharmaceuticals (276)
Rare diseases (530)
Real estate (6802)
Recruiting (73)
Regulatory (25575)
Reports (51)
Research institute (2644)
Resumes & cover letters (461)
Rett syndrome (10)
RNA editing (10)
RSV (60)
Schizophrenia (102)
Series A (172)
Series B (120)
Service/supplier (19)
Sickle cell disease (69)
Special edition (21)
Spinal muscular atrophy (164)
Sponsored (35)
Startups (4032)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (70)
The Weekly (75)
Vaccines (922)
Venture capital (58)
Weight loss (311)
Women's health (51)
Worklife (20)
Date
Today (8)
Last 7 days (543)
Last 30 days (1828)
Last 365 days (32621)
2025 (19068)
2024 (37267)
2023 (42252)
2022 (53556)
2021 (58300)
2020 (57303)
2019 (50830)
2018 (38595)
2017 (35492)
2016 (35993)
2015 (42374)
2014 (36649)
2013 (32912)
2012 (34659)
2011 (34907)
2010 (33987)
Location
Africa (1065)
Alabama (69)
Alaska (7)
Arizona (272)
Arkansas (14)
Asia (45648)
Australia (8378)
California (7915)
Canada (2476)
China (729)
Colorado (335)
Connecticut (352)
Delaware (209)
Europe (103849)
Florida (1186)
Georgia (274)
Hawaii (3)
Idaho (66)
Illinois (729)
India (31)
Indiana (388)
Iowa (18)
Japan (247)
Kansas (114)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1111)
Massachusetts (5994)
Michigan (275)
Minnesota (495)
Mississippi (4)
Missouri (106)
Montana (32)
Nebraska (25)
Nevada (87)
New Hampshire (74)
New Jersey (2220)
New Mexico (31)
New York (2217)
North Carolina (1220)
North Dakota (10)
Northern California (3477)
Ohio (255)
Oklahoma (17)
Oregon (38)
Pennsylvania (1704)
Puerto Rico (18)
Rhode Island (39)
South America (1428)
South Carolina (36)
South Dakota (1)
Southern California (2973)
Tennessee (131)
Texas (1210)
United States (29711)
Utah (232)
Virginia (209)
Washington D.C. (80)
Washington State (681)
West Virginia (4)
Wisconsin (84)
799,424 Results for "syneos health formerly known as inc research inventiv health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alzamend Neuro to Present at the 2025 Military Health System Research Symposium
July 29, 2025
·
5 min read
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity from taking control of the company to the detriment of other shareholders.
April 23, 2025
·
1 min read
·
Tristan Manalac
Press Releases
OMRON Healthcare Issues Urgent Health Message on AFib, Heart Failure Risks in Response to New Research
July 4, 2025
·
5 min read
Press Releases
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
May 9, 2025
·
8 min read
Press Releases
Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health
June 12, 2025
·
3 min read
Press Releases
Flatiron Health Research on AI-Driven Cancer Progression Extraction Presented at AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning 2025
July 14, 2025
·
3 min read
Press Releases
RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting
May 23, 2025
·
5 min read
Press Releases
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
June 10, 2025
·
4 min read
Business
Opinion: Investing in Research and Welcoming Global Talent Strengthens America
Recent decisions to reduce health and science research funding and limit the participation of international students and researchers could prove damaging in the short and long term.
June 4, 2025
·
4 min read
·
Dr. Chris Otiko
Press Releases
BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
August 1, 2025
·
25 min read
1 of 79,943
Next
